NovoCure Limited (NVCR)
NASDAQ: NVCR
· Real-Time Price · USD
11.73
0.14 (1.21%)
At close: Aug 15, 2025, 3:59 PM
11.79
0.51%
After-hours: Aug 15, 2025, 05:59 PM EDT
NovoCure Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 158.81M | 154.99M | 161.27M | 155.09M | 150.36M | 138.5M | 133.78M | 127.32M | 126.05M | 122.18M | 128.43M | 131M | 140.87M | 137.55M | 133.21M | 133.61M | 133.52M | 134.69M |
Cost of Revenue | 41.47M | 38.52M | 33.47M | 35.37M | 34.65M | 33.69M | 32.56M | 32.09M | 34.02M | 29.61M | 28.89M | 29.75M | 28.5M | 27.73M | 29.69M | 30.21M | 28.6M | 26.39M |
Gross Profit | 117.33M | 116.47M | 127.8M | 119.72M | 115.7M | 104.81M | 101.23M | 95.23M | 92.03M | 92.57M | 99.54M | 101.25M | 112.36M | 109.82M | 103.53M | 103.4M | 104.92M | 108.31M |
Operating Income | -39.52M | -37.87M | -63.3M | -32.09M | -33.61M | -41.52M | -51.72M | -58.24M | -62.66M | -60.25M | -42.98M | -24.61M | -21.13M | -806K | -23.4M | -8.55M | -12.29M | -88K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 13.18M | 10.02M | 8.76M | 9.17M | 10.42M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -34.98M | -30.3M | -55.21M | -21.59M | -22.73M | -31.64M | -38.53M | -48.22M | -53.9M | -51.08M | -32.56M | -23.42M | -23.36M | -2.52M | -25.57M | -10.53M | -13.23M | -2.73M |
Net Income | -40.14M | -34.32M | -65.92M | -30.57M | -33.38M | -38.76M | -47.08M | -49.48M | -57.42M | -53.06M | -37.3M | -26.58M | -24.01M | -4.65M | -26.46M | -13.12M | -14.64M | -4.13M |
Selling & General & Admin | 101.02M | 100.56M | 139.89M | 99.93M | 94.35M | 94.74M | 98.64M | 99.85M | 99.27M | 93.11M | 87.7M | 73.9M | 76.42M | 68.39M | 69.99M | 63.81M | 66.9M | 62.48M |
Research & Development | 55.83M | 53.78M | 51.21M | 51.88M | 54.95M | 51.6M | 54.31M | 53.62M | 55.43M | 59.7M | 54.82M | 51.96M | 57.08M | 42.23M | 56.93M | 48.14M | 50.31M | 45.92M |
Other Expenses | n/a | n/a | n/a | n/a | -27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 156.85M | 154.34M | 191.1M | 151.81M | 149.31M | 146.33M | 152.94M | 153.47M | 154.69M | 152.82M | 142.52M | 125.86M | 133.49M | 110.63M | 126.92M | 111.95M | 117.21M | 108.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 9.17M | n/a | n/a | n/a | 13.94M | 1.19M | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 57.07M | 55.79M | 67.41M | 59.83M | 56.62M | 55.21M | 59.19M | 57.96M | 58.49M | 51.17M | 49.63M | 41.4M | 44.75M | 37.88M | 38.98M | 32.58M | 34.14M | 31.36M |
Cost & Expenses | 198.33M | 192.86M | 224.57M | 187.19M | 183.96M | 180.02M | 185.5M | 185.57M | 188.71M | 182.43M | 171.41M | 155.61M | 161.99M | 138.35M | 156.61M | 142.16M | 145.81M | 134.78M |
Income Tax Expense | 5.16M | 4.02M | 10.72M | 8.98M | 10.65M | 7.12M | 8.54M | 1.26M | 3.51M | 1.98M | 4.75M | 3.16M | 652K | 2.13M | 885K | 2.59M | 1.41M | 1.39M |
Shares Outstanding (Basic) | 111.57M | 110.28M | 107.83M | 108.25M | 107.7M | 107.27M | 106.98M | 106.77M | 106.29M | 105.67M | 105.03M | 104.88M | 104.63M | 104.19M | 103.88M | 100.95M | 103.48M | 102.63M |
Shares Outstanding (Diluted) | 111.57M | 110.28M | 107.83M | 108.25M | 107.7M | 107.27M | 106.98M | 106.77M | 106.29M | 105.67M | 105.03M | 104.88M | 104.63M | 104.19M | 103.88M | 103.73M | 103.48M | 102.63M |
EPS (Basic) | -0.36 | -0.31 | -0.61 | -0.28 | -0.31 | -0.36 | -0.44 | -0.46 | -0.54 | -0.5 | -0.36 | -0.25 | -0.23 | -0.04 | -0.25 | -0.13 | -0.14 | -0.04 |
EPS (Diluted) | -0.36 | -0.31 | -0.61 | -0.28 | -0.31 | -0.36 | -0.44 | -0.46 | -0.54 | -0.5 | -0.36 | -0.25 | -0.23 | -0.04 | -0.25 | -0.13 | -0.14 | -0.04 |
EBITDA | -36.08M | -34.54M | -10.52M | -29.63M | -30.75M | -36.67M | -35.81M | -55.44M | -59.94M | -57.53M | -29.86M | -21.95M | -18.47M | 1.8M | -20.73M | -5.82M | -9.81M | 2.28M |
EBIT | -39.52M | -37.87M | -13.63M | -32.09M | -33.58M | -41.52M | -38.53M | -58.24M | -62.66M | -60.25M | -32.56M | -24.61M | -21.13M | -806K | -23.4M | -8.55M | -12.29M | -88K |
Depreciation & Amortization | 3.44M | 3.33M | 3.1M | 2.46M | 2.86M | 2.81M | 2.72M | 2.8M | 2.72M | 2.72M | 2.7M | 2.66M | 2.65M | 2.61M | 2.67M | 2.73M | 2.48M | 2.37M |